1 / 14

Microencapsulation of Leydig cells

Microencapsulation of Leydig cells. Team: Bryan Baxter Tim Eng Joe Zechlinski April Zehm BME 400 October 14, 2005. Client: Dr. Craig Atwood Dr. Sivan Vadakkadath Meethal Miguel Gallego VA Hospital Advisor: Assistant Professor Kristyn Masters Department of Biomedical Engineering.

Télécharger la présentation

Microencapsulation of Leydig cells

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Microencapsulation of Leydig cells Team: Bryan Baxter Tim Eng Joe Zechlinski April Zehm BME 400 October 14, 2005

  2. Client:Dr. Craig AtwoodDr. Sivan Vadakkadath MeethalMiguel GallegoVA HospitalAdvisor:Assistant Professor Kristyn MastersDepartment of Biomedical Engineering

  3. Overview • Problem Statement • Background • Design Specifications • Recap of previous work • New directions

  4. Problem Statement • Develop method of encapsulating cells to allow hormone release while providing a physical barrier to the host’s immune system Motivation • Potential alternative to less desirable treatments • Organ transplant • Hormone injections • Cellular grafts

  5. Microcapsules • Provide physical barrier to immune system • Consist of hydrogels • Implanted in vivo • Time-released hormone therapy (Uludag et al., 2000)

  6. Client Research • Microencapsulation applications • Anti-aging therapy • Reproductive disorders • Cells and hormones of interest • Leydig and Sertoli cells • Testosterone, inhibin, activin, FSH, LH (Ownby, 1999) (Adapted from Morohashi, 1997)

  7. Biocompatibility Material properties Crosslinking procedure Repeatability of results Immunoprotection Controlled pore size (MWCO) Degradation Mechanical Biological Design Specifications

  8. Previous work • Polyethylene glycol (PEG) • Diacrylated synthetic polymer • UV-crosslinked • Water-in-oil emulsification

  9. Previous work • Bioprinter • Modified Epson R200 inkjet printer • Piezoelectric droplet generation • Linux platform, software interface

  10. Microsphere Production • Microfluidic devices • Increased precision and control on microscale • Sample and sheath flow rates determine size and quantity of microcapsules • Minimal reagents used (Jeong et al., 2005)

  11. Cell culture • Cell line • MA-10 cells (mouse cancer Leydig cells) • Produce testosterone • Cell passaging • Split proliferating cells • Hemocytometry • Cryofreezing (Saltzman, 2004.)

  12. PEG hydrogels on the macroscale • Current Experiments: • Acrylation procedure • Hydrogel swelling/PEG crosslinking • Planned Experiments: • Combine with MA-10 cell suspension 12.5x

  13. (http://respiratory-research.com) Viability/Hormone studies • Live/Dead® assay • Metabolism (greenlive) • Membrane integrity (reddead) • Testosterone assay • Competitive sandwich ELISA (ALPCO Diagnostics)

  14. References Jeong, W., et al. 2005. Continuous fabrication of biocatalyst immobilized microparticles using photopolymerization and immiscible liquids in microfluidic systems. Langmuir 21: 3738-3741. Machluf M, Orsola A, Boorjian S, Kershen R, and Atala A. 2003. Microencapsulation of leydig cells: a system for testosterone supplementation. Endocrinology 144:4975-4979. Morohashi, K. 1997. The ontogenesis of the steroidogenic tissues. Genes to Cells 2: 95-106. Ownby. 1999. Histology: male reproductive system. http://www.cvm.okstate.edu/instruction/mm_curr/histology/MR/HiMRp3.htm. Accessed February 12, 2005. Saltzman, W. 2004. Tissue engineering : engineering principles for the design of replacement organs and tissues. New York : Oxford University Press. Uludag H, De Vos P, and Tresco PA. 2000. Technology of mammalian cell encapsulation. Advanced Drug Delivery Reviews 42:29-64. http://chemfinder.cambridgesoft.com http://respiratory-research.com http://web.indstate.edu/thcme/mwking/glycans.html http://www.cybercolloids.net/library/alginate/structure.php

More Related